[VEGF, COX-2 and MVD in lesions of patients with condyloma acuminatum]
Related Experiment Video
Updated: Jun 23, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
1Department of Dermatology, the First Affiliated Hospital, Medical School of Xi 'an Jiaotong University, Xi' an 710061, China.
Objective:
To determine the roles of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) in the occurrence and development of condyloma acuminatum (CA).
Methods:
The VEGF, COX-2, and microvascular density (MVD) in the lesions of 61 CA patients were detected with immunohistochemical SP method. Seventeen skin tissues from healthy men served as controls.
Results:
The CA patients had greater positive rate and field-strength scores of VEGF and COX-2 than the controls (P < 0.05). VEGF positively correlated with COX-2 in the CA lesions (r = 0.749, P < 0.05). With the increase of number and diameters of CA lesions, the field-strength scores of VEGF and COX-2 increased (P < 0.05). The positive rates and field-strength scores did not change with the courses of the CA disease (P > 0.05). The CA lesions also had greater MVD than the controls (P < 0.05). The CA lesions with positive VEGF and COX-2 had greater MVD than those with negative VEGF and COX-2 (P < 0.05). Both VEGF and COX-2 were positively correlated with MVD (r = 0.348 and 0.327 respectively, P < 0.05).
Conclusion:
VEGF and COX-2 promote the abnormal angiogenesis and the cell proliferation in CA lesions, which accelerate the progress of wart lesions. The two factors have synergistic
Related Concept Videos
Vascular Spasm
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Complications

